Determination of the absolute configuration of the nonsteroidal contraceptive agent centchroman by X-ray crystallography on its N-methyl iodide salt

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 15, 1996, Pages 1747-1752

  Srivastava, Neeta ^a   Ray, Suprabhat ^a   Dwivedy, Indra ^a   Wilson, Scott R ^b   Hom, Roy K ^b   Katzenellenbogen, John A ^b  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTCHROMAN;

ARTICLE; CHIRALITY; DRUG STRUCTURE; X RAY CRYSTALLOGRAPHY;

EID: 0030572476     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00309-5     Document Type: Article

References (26)

1. 1. Kamboj, V. P.; Ray, S.; Dhawan, B. N. Drugs Today 1992, 28, 227.
2. 2. (a) Jordan, V. C.; Murphy, C. S. Endocr. Rev. 1990, 11, 578.
3. (b) Furr, B. J.; Jordan, V. C. Pharmacol. Ther. 1984, 25, 127.
4. 3. Salman, M.; Ray, S.; Anand, N.; Agarwal, A. K.; Singh, M. M.; Selty, B. S.; Kamboj, V. P. J. Med. Chem. 1986, 29, 1801.
5. 4. Ray, S.; Tandon, A.; Dwivedy, I.; Wilson, S. R.; O'Neil, J. P.; Katzenellenbogen, J. A. J. Med. Chem. 1994, 37, 696.
6. 5. International Tables for X-ray Crystallography; Wilson, A. J. C., Ed.; Dordrecht: Kluwer Academic, 1992; Vol. C:
7. (a) scattering factors, pp 500-502;
8. (b) anomalous dispersion corrections, pp 219-222.
9. 6. Sheldrick, G. M. Acta Crystallogr. Sect. A 1990, 46, 467.
10. 7. Sheldrick, G. M. SHELXL-93. Program for crystal structure refinement. Göttingen, Germany: Institute fur anorg chemie, 1993.
11. 8. Flack, H. D. Acta Crystallogr. Sect. A 1983, 39, 876.
12. 9. Siemens Industrial Automation, Incorporated. SAINT V4; SHELXTL V5; SMART V4. Madison, Wisconsin, USA: 1994.
13. 10. a) Ratna, S.; Roy, S. K.; Ray, S.; Kole, P. L.; Salman, M.; Madhusudan, K. P.; Sircar, K. P.; Anand, N. Drug Dev. Res. 1986, 7, 173.
14. b) Paliwal, J. K.; Gupta, R. C. Drug Metab. Dispos. 1996, 24, 148.
15. 11. Katzenellenbogen, J. A.; Johnson, H. J., Jr.; Myers, H. N. Biochemistry 1973, 12, 4085.
16. 12. Lan, N. C.; Katzenellenbogen, B. S. Endocrinology 1975, 98, 220.
17. 13. Landvatter, S. W.; Katzenellenbogen, J. A. Mol. Pharmacol. 1981, 20, 43.
18. 14. Edgren, R. A.; Jones, R. C. Steroids 1969, 14, 335.
19. 15. Salman, M. Ph.D. Thesis, University of Aligarh, India, 1982.
20. 16. See footnote 24 in reference 4.
21. 17. (a) Zeelen, F. J.; Bergink, E. W. In Cytotoxic Estrogens in Hormone Receptor Tumors; Raus, J. Martens H., LeClercq, G., Eds.; London: Academic, 1980; pp 39-48.
22. (b) The estrogen receptor is tolerant of estrogens bearing sizable substituents at the 11β position: Pomper, M. G.; VanBrocklin, H.; Thieme, A. M.; Thomas, R. D.; Kiesewetter, D. O.; Carlson, K. E.; Mathias, C. J.; Welch, M. J.; Katzenellenbogen, J. A. J. Med. Chem. 1990, 33, 3143 and references cited therein.
23. (c) French, A. N.; Wilson, S. R.; Welch, M. J.; Katzenellenbogen, J. A. Steroids 1993, 58, 157 and references cited therein.
24. (d) An extensive study of receptor binding and uterotrophic activity has shown that the affinity and potency of various centchroman analogs are quite sensitive to the nature of C-2 substituents: Durani, S.; Agarwal, A. K.; Saxena, R.; Setty, B. S.; Gupta, R. C.; Kole, P., I.; Ray, S.; Anand, N. J. Steroid Biochem. 1979, 11, 67.
25. 15
26. 19. Robertson, D. W.; Katzenellenbogen, J. A.; Long, D. J.; Rorke, E. A.; Katzenellenbogen B. S. J. Steroid Biochem. 1982, 16, 1 and references cited therein.